Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Public ClinicalTrials.gov record NCT03926624. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Randomized Trial of DFP-10917 vs Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Venetoclax Combination Regimens) or Intensive Reinduction (High & Intermediate Dose Cytarabine Regimens) for Acute Myelogenous Leukemia Patients in Second, Third, or Fourth Salvage
Study identification
- NCT ID
- NCT03926624
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Delta-Fly Pharma, Inc.
- Industry
- Enrollment
- 167 participants
Conditions and interventions
Conditions
Interventions
- DFP-10917 Drug
- Cytarabine Drug
- Azacitidine Drug
- Decitabine Drug
- Mitoxantrone Drug
- Etoposide Drug
- Fludarabine Drug
- Idarubicin Drug
- Venetoclax Drug
- Cladribine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 21, 2019
- Primary completion
- Jan 6, 2026
- Completion
- Jan 6, 2026
- Last update posted
- Jan 21, 2026
2019 – 2026
United States locations
- U.S. sites
- 39
- U.S. states
- 21
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| O'Neal Comprehensive Cancer Center | Birmingham | Alabama | 35294 | — |
| Banner MD Anderson | Gilbert | Arizona | 85234 | — |
| HonorHealth (VGPCC Cancer Transplant Institute) | Scottsdale | Arizona | 85258 | — |
| The University of Arizona Cancer Center | Tucson | Arizona | 85724-5024 | — |
| University of California | Irvine | California | 92697 | — |
| UCLA | Los Angeles | California | 90095 | — |
| UF-Health Cancer Center Gainesville | Gainesville | Florida | 32608 | — |
| Baptist MD Anderson | Jacksonville | Florida | 32207 | — |
| UF-Health Jacksonville | Jacksonville | Florida | 32209 | — |
| AdventHealth Medical Group Blood and Marrow Transplant at Orlando | Orlando | Florida | 32804 | — |
| Georgia Cancer Center at Augusta University | Augusta | Georgia | 30912 | — |
| Rush University | Chicago | Illinois | 60612 | — |
| Decatur Memorial Hospital-Cancer Care Specialists of Central IL | Decatur | Illinois | 62526 | — |
| Loyola University Medical Center | Hines | Illinois | 60153 | — |
| Franciscan Health Indianapolis | Indianapolis | Indiana | 46237 | — |
| The University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| University of KY- Markey Cancer Center | Lexington | Kentucky | 40536 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40241 | — |
| Ochsner Benson Cancer Center | Jefferson | Louisiana | 70121 | — |
| Tulane University | New Orleans | Louisiana | 70118 | — |
| Henry Ford Cancer Institute | Detroit | Michigan | 48202 | — |
| The University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| New York Medical College | Valhalla | New York | 10595 | — |
| Novant Health Cancer Institute - Elizabeth (Hematology) | Charlotte | North Carolina | 28204 | — |
| East Carolina University | Greenville | North Carolina | 27834 | — |
| Vidant Oncology | Kinston | North Carolina | 28501 | — |
| Novant Health Cancer Institute - Forsyth (Hematology) | Winston-Salem | North Carolina | 27103 | — |
| Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | North Carolina | 27157 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| University of Cincinnati Cancer Center | Cincinnati | Ohio | 45267 | — |
| Seidman Cancer Center, University Hospitals, Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Prisma Health Cancer Institute | Greenville | South Carolina | 29605 | — |
| Avera Medical Group | Sioux Falls | South Dakota | 57105 | — |
| UT Southwestern | Dallas | Texas | 75390 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| University of Vermont Medical Center | Burlington | Vermont | 05401 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22903 | — |
| Multicare Institute for Research and Innovation | Spokane | Washington | 99218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03926624, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03926624 live on ClinicalTrials.gov.